Sfoglia per Afferenza Dipartimento di Medicina clinica, sanità pubblica, scienze della vita e dell'ambiente

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 8.774 a 8.793 di 18.318
Titolo Data di pubblicazione Autore(i) File
Interference of antisperm antibodies with the induction of the acrosome reaction by zona pellucida (ZP) and its relationship with the inhibition of ZP binding 1-gen-1997 Francavilla, Felice; Romano, R; Santucci, R; Marrone, V; Properzi, Giuliana; Ruvolo, G.
Interferenze della terapia antalgica con le risposte cardiocircolatorie al trauma. 1-gen-1996 Ciccozzi, Alessandra; Varrassi, G.
The interhemispheric transcallosal-transversal approach to the lesions of the anterior and middle third ventricle: surgical validity and neuropsychological evaluation of the outcome 1-gen-2004 Mazza, Monica; Di Renzo, A; Costagliola, C; Roncone, Rita; Casaccia, M; Ricci, A; Galzio, Renato
Interleuckin-2 and 13-CIS retinoic acid as treatment of ovarian cancer stem cells 1-gen-2009 Recchia, F; Camdeloro, G; Necozione, S; Bisegna, R; Carta, Gaspare; Rea, S.
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 1-gen-2008 Vincenzi, B; Patti, G; Galluzzo, S; Pantano, F; Venditti, O; Santini, D; Ruzzo, A; Schiavon, G; Caraglia, M; Marra, M; Graziano, F; Tonini, G
Interleukin 2 (Il2) production and Il2 receptor release in type I diabetes 1-gen-1989 Cavallo, Mg; Signore, A; Baroni, M. G.; Andreani, D; Pozzilli, P
Interleukin 7 engineered stromal cells: a new approach for hastening naive T cell recruitment 1-gen-2005 DI IANNI, Mauro; DEL PAPA, B; DE IOANNI, M; Terenzi, A; Sportoletti, P; Moretti, L; Falzetti, F; Gaozza, E; Zei, T; Spinozzi, F; Bagnis, C; Mannoni, P; Bonifacio, E; Falini, B; Martelli, Mf; Tabilio, A.
Interleukin 7 retroviral gene transfer in human stromal cells enhances th survival of naive T lymphocytes 1-gen-2003 DI IANNI, Mauro; B., Del Papa; M., De Ioanni; P., Sportoletti; L., Moretti; E., Ayroldi; F., Falzetti; Martelli, M. F.; A., Tabilio
Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model 1-gen-2018 Gabellini, C.; Gomez-Abenza, E.; Ibanez-Molero, S.; Tupone, M. G.; Perez-Oliva, A. B.; de Oliveira, S.; Del Bufalo, D.; Mulero, V.
Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction 1-gen-2005 Patti, G; Mega, S; Pasceri, V; Nusca, A; Giorgi, G; Zardi, Em; D'Ambrosio, A; Dobrina, A; Di Sciascio, G
Interleukin-1 receptor antagonist: A sensitive marker of instability in patients with coronary artery disease 1-gen-2002 Patti, G; D'Ambrosio, A; Dobrina, A; Dicuonzo, G; Giansante, C; Fiotti, N; Abbate, A; Guarnieri, G; Di Sciascio, G
Interleukin-18 in obese children and adolescents: new marker of inflammation and endothelial cell activation 1-gen-2007 De Simone, M; Iezzi, Ml; Desideri, Giovambattista; Ferri, Claudio; Raiola, G; Pellegrino, K; Pezone, I.
Interleukin-1beta specifically stimulates nitric oxide production in the hypothalamus 1-gen-1996 Brunetti, L; Volpe, ANNA RITA; Ragazzoni, E; Preziosi, P; Vacca, M.
Interleukin-1beta stimulates nitric oxide release from cultured rat hypothalamic cells in vitro 1-gen-1995 L., Brunetti; Volpe, ANNA RITA; E., Ragazzoni; P., Preziosi; M., Vacca
Interleukin-1beta-producing plasma cells in close contact with hepatocytes in patients with chronic active hepatitis 1-gen-1997 Hassan, G; Moreno, S; Massimi, Mara; DI BIAGIO, P; Stefanini, S.
. Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) decrease vascular endothelial growth factor (VEGF) and prolong disease-free and overall survival in patients with non small cell lung cancer (NSCLC) responsive to chemotherapy. J Clin Oncol 2005: 23, 234s (supplement), abstract #3171. 1-gen-2005 Recchia, F; Saggio, G; Cesta, A; Candeloro, G; Nuzzo, A; Lombardo, M; Rea, Silvio
Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) decrease vascular endothelial growth factor (VEGF) and prolong clinical benefit in patients with advanced solid tumors showing a partial response (PR) or stable disease (SD) to chemotherapy. J Clin Oncol 2005: 2, 27s (supplement). 1-gen-2005 Saggio, G; Cesta, A; Amiconi, G; Di Blasio, A; Candeloro, G; Alesse, E; Rea, Silvio
Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) dicrease serum vascular endothelial growth factor (VEGF) of patients with platinum sensitive, advanced ovarian cancer (AOC) 1-gen-2005 Recchia, F; Cesta, A; Candeloro, G; Saggio, G; Nuzzo, A; Lalli, A; Lombardo, M; Carta, Gaspare; Rea, S.
Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) prolong disease- free and overall survival in recurrent ovarian cancer (ROC).Annals of Oncology, 2004, 15: 131, abstract # 491P. 1-gen-2004 F., Recchia; G., Saggio; A., Cesta; A., Nuzzo; Carta, Gaspare; Rea, Silvio
Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) prolong disease-free and overall survival in recurrent ovarian cancer (ROC) 1-gen-2004 Recchia, F; Saggio, G; Cesta, A; Nuzzo, A; Carta, Gaspare; Rea, S.
Mostrati risultati da 8.774 a 8.793 di 18.318
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile